Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ningbo Oulike Biological Technology is a specialized biotechnology company headquartered in Ningbo, China, focusing on the in vitro diagnostics (IVD) industry. Established in 2015, the company has developed a robust portfolio of diagnostic raw materials, including high-affinity monoclonal antibodies and recombinant antigens. Their product offerings extend to finished diagnostic kits for infectious diseases, cardiovascular health, and inflammatory markers. Oulike utilizes advanced technology platforms such as colloidal gold, fluorescence immunochromatography, and chemiluminescence to ensure high sensitivity and specificity in their assays. The company serves a global clientele, providing both standardized products and customized reagent development services. With a commitment to quality, Oulike maintains rigorous manufacturing standards to support clinical laboratories and healthcare providers worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ningbo OULAIKE.